摘要
细菌性呼吸道感染是囊性纤维化(CF)患者发病和死亡的主要原因。 在幼儿期,呼吸道感染是由于金黄色葡萄球菌和流感嗜血杆菌。 在老年CF患者中,更常见于病原性革兰氏阴性细菌,如无色杆菌,洋葱伯克霍尔德菌,尤其是铜绿假单胞菌。 铜绿假单胞菌是CF中呼吸系统疾病的转折点,其优势随年龄增长而增加。 细菌使用各种双组分系统(TCS)来差异表达涉及急性和慢性感染的毒力因子。 在这里,我们将细菌TCS作为CF患者抗菌治疗的目标。
关键词: 细菌感染,囊性纤维化,双组分系统,抗菌治疗,呼吸道感染,病原体。
Current Drug Targets
Title:Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients
Volume: 18 Issue: 6
关键词: 细菌感染,囊性纤维化,双组分系统,抗菌治疗,呼吸道感染,病原体。
摘要: Bacterial respiratory infections are the main reason of morbidity and mortality among cystic fibrosis (CF) patients. In early childhood, the respiratory infections are due to Staphylococcus aureus and Haemophilus influenzae. In older CF patients, pathogenic Gram-negative bacteria like Achromobacter xylosoxidans, Burkholderia cepacia complex and especially Pseudomonas aeruginosa are more frequently seen. P. aeruginosa is a turning point in the respiratory disease in CF and its predominance increases with age. Bacteria use a variety of two-component systems (TCS) to differentially express virulence factors involved in both acute and chronic infections. Here, we review bacterial TCS as targets for antibacterial treatment for CF patients.
Export Options
About this article
Cite this article as:
Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients, Current Drug Targets 2017; 18 (6) . https://dx.doi.org/10.2174/1389450117666160208145934
DOI https://dx.doi.org/10.2174/1389450117666160208145934 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epigenetics: New Concepts of Old Phenomena in Vascular Physiology
Current Vascular Pharmacology Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Management of Neonatal Liver Tumors
Current Pediatric Reviews The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Ketogenic Diets in the Treatment of Epilepsy
Current Pharmaceutical Design The Emerging Role of Unmetabolized Folic Acid in Human Diseases: Myth or Reality?
Current Drug Metabolism Genetic Enhancement in Sport: Just Another Form of Doping?
Recent Patents on DNA & Gene Sequences From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews Positive Social Interactions in a Lifespan Perspective with a Focus on Opioidergic and Oxytocinergic Systems: Implications for Neuroprotection
Current Neuropharmacology Editorial: The Impact of a Life Threatening Disease on the Growth and Development of the Pediatric Patient
Current Pediatric Reviews Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors
Current Pediatric Reviews Critical Aspects to be Considered Prior to Large-Scale Production of Peptides
Current Protein & Peptide Science Focus on MicroRNAs as Biomarker in Pediatric Diseases
Current Pharmaceutical Design Biology and Clinical Relevance of Mannose-Binding Lectin
Drug Design Reviews - Online (Discontinued) Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes
Current Drug Targets Proteostasis, an Emerging Therapeutic Paradigm for Managing Inflammatory Airway Stress Disease
Current Molecular Medicine Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Application of MALDI/SELDI Mass Spectrometry to Cancer Biomarker Discovery and Validation
Current Proteomics Double-Edged Sword of Novel Anti-Cancer Treatment: Proteasome Inhibition in the Growth Plate Causes Impairment of Longitudinal Bone Growth
Current Pediatric Reviews Translational Gap in Glioma Research
Anti-Cancer Agents in Medicinal Chemistry